Sofinnova Investments, Inc. Xencor Inc Transaction History

Sofinnova Investments, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$19.74 - $29.01 $2.29 Million - $3.36 Million	-115,828 Reduced 42.27%	158,164 $4.33 Million
Q1 2022 May 16, 2022	SELL	$26.68 - $41.63 $7.02 Million - $11 Million	-263,038 Reduced 48.98%	273,992 $7.31 Million
Q4 2021 Feb 14, 2022	BUY	$33.67 - $43.44 $18.1 Million - $23.3 Million	537,030 New	537,030 $21.5 Million
Q2 2019 Aug 13, 2019	SELL	$29.6 - $40.93 $6.21 Million - $8.59 Million	-209,907 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$27.85 - $38.09 $284,766 - $389,470	10,225 Added 5.12%	209,907 $6.52 Million
Q4 2018 Feb 14, 2019	BUY	$32.39 - $42.05 $6.47 Million - $8.4 Million	199,682 New	199,682 $7.22 Million

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.44B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Sofinnova Investments, Inc. with notifications on news.